These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 6125941)

  • 21. Stimulation of the receptor for melanocyte-stimulating hormone by retinoic acid.
    Chakraborty AK; Orlow SJ; Pawelek JM
    FEBS Lett; 1990 Dec; 276(1-2):205-8. PubMed ID: 2265702
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alpha tocopheryl succinate inhibits melanocyte-stimulating hormone (MSH)-sensitive adenylate cyclase activity in melanoma cells.
    Sahu SN; Edwards-Prasad J; Prasad KN
    J Cell Physiol; 1987 Dec; 133(3):585-9. PubMed ID: 3693413
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Melanocyte-stimulating hormone promotes activation of pre-existing tyrosinase molecules in Cloudman S91 melanoma cells.
    Wong G; Pawelek J
    Nature; 1975 Jun; 255(5510):644-6. PubMed ID: 806022
    [No Abstract]   [Full Text] [Related]  

  • 24. Altered polyamine metabolism in Chinese hamster cells growing in a defined medium.
    Sertich GJ; Glass JR; Fuller DJ; Gerner EW
    J Cell Physiol; 1986 Apr; 127(1):114-20. PubMed ID: 3958058
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Difluoromethylornithine irreversibly inactivates ornithine decarboxylase of Pseudomonas aeruginosa, but does not inhibit the enzymes of Escherichia coli.
    Kallio A; McCann PP
    Biochem J; 1981 Oct; 200(1):69-75. PubMed ID: 6800359
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Requirement for transglutaminase in the activation of latent transforming growth factor-beta in bovine endothelial cells.
    Kojima S; Nara K; Rifkin DB
    J Cell Biol; 1993 Apr; 121(2):439-48. PubMed ID: 8096847
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Indirect evidence for a strict negative control of S-adenosyl-L-methionine decarboxylase by spermidine in rat hepatoma cells.
    Mamont PS; Joder-Ohlenbusch AM; Nussli M; Grove J
    Biochem J; 1981 May; 196(2):411-22. PubMed ID: 6797404
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nature of the increase in renal ornithine decarboxylase activity after cycloheximide administration in the rat.
    Levine JH; Nicholson WE; Orth DN
    Proc Natl Acad Sci U S A; 1975 Jun; 72(6):2279-83. PubMed ID: 806079
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TGF-beta receptors are diminished after retinoid exposure in rat liver epithelial cells.
    Mercier T; Gaillard-Sanchez I; Martel P; Heberden C
    J Cell Biochem; 1996 May; 61(2):230-7. PubMed ID: 9173086
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation of ornithine decarboxylase in monolayer cells treated with trypsin.
    Gerner EW; Glass JR; Fuller DJ
    J Cell Physiol; 1985 Dec; 125(3):567-72. PubMed ID: 3840806
    [TBL] [Abstract][Full Text] [Related]  

  • 31. alpha-Difluoromethylornithine, an irreversible inhibitor of ornithine decarboxylase, inhibits tumor promoter-induced polyamine accumulation and carcinogenesis in mouse skin.
    Weeks CE; Herrmann AL; Nelson FR; Slaga TJ
    Proc Natl Acad Sci U S A; 1982 Oct; 79(19):6028-32. PubMed ID: 6821130
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Melanoma cells resistant to inhibition of growth by melanocyte stimulating hormone.
    Pawelek J; Sansone M; Koch N; Christie G; Halaban R; Hendee J; Lerner AB; Varga JM
    Proc Natl Acad Sci U S A; 1975 Mar; 72(3):951-5. PubMed ID: 165495
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Measurement of the number of ornithine decarboxylase molecules in rat and mouse tissues under various physiological conditions by binding of radiolabelled alpha-difluoromethylornithine.
    Seely JE; Pösö H; Pegg AE
    Biochem J; 1982 Aug; 206(2):311-8. PubMed ID: 6816220
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induction of major chromosome aberrations in Chinese hamster ovary cells by alpha-difluoromethylornithine.
    Pohjanpelto P; Knuutila S
    Cancer Res; 1984 Oct; 44(10):4535-9. PubMed ID: 6432316
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Depigmenting mechanisms of all-trans retinoic acid and retinol on B16 melanoma cells.
    Sato K; Morita M; Ichikawa C; Takahashi H; Toriyama M
    Biosci Biotechnol Biochem; 2008 Oct; 72(10):2589-97. PubMed ID: 18838813
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of transglutaminase activity in Chinese hamster ovary cells.
    Milhaud PG; Davies PJ; Pastan I; Gottesman MM
    Biochim Biophys Acta; 1980 Jul; 630(4):476-84. PubMed ID: 6104988
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of inhibitors of ornithine decarboxylase on the differentiation of mouse neuroblastoma cells.
    Chen KY; Nau D; Liu AY
    Cancer Res; 1983 Jun; 43(6):2812-8. PubMed ID: 6303569
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prolonged stimulation of S91 melanoma tyrosinase by [Nle4, D-Phe7]-substituted alpha-melanotropins.
    Abdel Malek ZA; Kreutzfeld KL; Marwan MM; Hadley ME; Hruby VJ; Wilkes BC
    Cancer Res; 1985 Oct; 45(10):4735-40. PubMed ID: 2992767
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early induction of mouse urinary bladder ornithine decarboxylase activity by rodent vesical carcinogens.
    Matsushima M; Bryan GT
    Cancer Res; 1980 Jun; 40(6):1897-901. PubMed ID: 7371022
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activation and de novo synthesis of transglutaminase in cultured glioma cells.
    Korner G; Bachrach U
    J Cell Physiol; 1985 Sep; 124(3):379-85. PubMed ID: 2413053
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.